Botswana vs Hong Kong, China: Previously treated cases tested for RR-/MDR-TB
Botswana
87.0%
in 2024
Hong Kong, China
87.0%
in 2024
Botswana rank
92nd
Hong Kong, China rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Botswana
- Hong Kong, China
How they compare
Botswana currently reports 87.0% against 87.0% in Hong Kong, China, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2008 it was Hong Kong, China ahead.
Botswana ranks 92nd and Hong Kong, China ranks 92nd of 180 countries.
Across the 3 decades both report, Botswana averaged higher in 1 and Hong Kong, China in 2.
Head to head by decade
| Decade | Botswana | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 50.5% | 26.0% | Hong Kong, China |
| 2010s | 21.8% | 57.4% | 35.6% | Hong Kong, China |
| 2020s | 93.5% | 87.0% | 6.5% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Botswana or Hong Kong, China?
- Botswana, at 87.0% against 87.0% in Hong Kong, China as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Botswana and Hong Kong, China?
- 0.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Hong Kong, China?
- 12 years are reported by both, from 2008 to 2024.
- How do Botswana and Hong Kong, China rank globally for previously treated cases tested for rr-/mdr-tb?
- Botswana ranks 92nd and Hong Kong, China ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.